Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations

Clinical trial NCT06517953 · RECRUITING

Trial details

NCT number: NCT06517953
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic EGFR G719X EGFR L861Q EGFR S768I

Start date: 2024-07-17
Primary completion: 2026-07-30
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.